Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, Texas Children's Hospital, BCM, Houston, Texas
1998
Residency, Penn State University Milton S. Hershey Medical Center
1995
Bachelor of Medicine, Bachelor of Surgery, Aga Khan University
1990
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Chronic Kidney Disease in Children (CKiD) Study
Kiessling, S. (PI), Chishti, A. (CoI) & Murphy, M. (CoI)
Childrens Hospital of Philadelphia
9/15/23 → 7/31/26
Project: Research project
-
GIGA-kids: Genomics of IgA-Related Diseases in Kids
Chishti, A. (PI)
Pediatric Nephrology Research Consortium Incorporated
7/24/23 → 12/30/25
Project: Research project
-
CUREGN 2.0 Midwest Pediatric Nephrology Consortium - PCC
Chishti, A. (PI)
Research Institute at Nationwide Childrens Hospital
6/1/20 → 5/31/24
Project: Research project
-
Chronic Kidney Disease in Children (CKiD)
Kiessling, S. (PI), Chishti, A. (CoI), Murphy, M. (CoI) & Murphy, M. (CoI)
Childrens Hospital of Philadelphia
8/1/18 → 8/16/23
Project: Research project
-
Integrative Proteomics and Metabololmics for Pediatric Glomerula Disease Biomarkers
Chishti, A. (PI)
Research Institute at Nationwide Childrens Hospital
7/2/18 → 5/31/19
Project: Research project
-
Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) Network
GlomeruloNephropathy (CureGN) Study Consortium, Jun 2025, In: Kidney Medicine. 7, 6, 100877.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental Glomerulosclerosis
Cure GlomeruloNephropathy (CureGN) Study Consortium, Apr 2025, In: Kidney Medicine. 7, 4, 100975.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Significance of Immune Deposits and Complement System Activation in FSGS: Findings from the Cure Glomerulonephropathy Network Study
CureGN Consortium, Aug 1 2025, In: Kidney360. 6, 8, p. 1384-1393 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Defining subgroups of pediatric nephrotic patients with urine proteomics
CureGN Participating Clinical Centers (PCC) through the University of North Carolina, CureGN Participating Clinical Centers (PCC) through the Pediatric Nephrology Research Consortium, CureGN Participating Clinical Centers (PCC) through Columbia University, Cure Glomerulonephropathy (CureGN) Consortium, Steering Committee Chair, Data Coordinating Center (DCC) & CureGN Participating Clinical Centers (PCC) through the University of Pennsylvania, Dec 2025, In: Scientific Reports. 15, 1, 25064.Research output: Contribution to journal › Article › peer-review
Open Access -
Family History in the Context of CKD
CRIC Study Investigators and the CureGN Study, Aug 1 2025, In: Journal of the American Society of Nephrology. 36, 8, p. 1561-1571 11 p.Research output: Contribution to journal › Article › peer-review